By Kirstin R Matthews, Bhavana Kunisetty and Keri Sprung
The connection between Texas H.B. 810, which allows clinics to provide investigational stem cell treatments to certain patients, and a deregulation movement to increase patient access to unproven stem cell treatments is described in this report. Stem Cells and Development: http://bit.ly/2CrEDEj.
Sept. 6, 2018, 3:27 p.m.
Maude Rowland Cuchiara, Ph.D., is a nonresident scholar for the Science and Technology Policy Program. Cuchiara actively works with the International Stem Cell Policy Program to research and write science policy reports and peer-reviewed publications. She is specifically interested …
Peter J. Hotez, M.D., Ph.D., is the Baker Institute fellow in disease and poverty. He is dean of the National School of Tropical Medicine and professor of pediatrics and molecular virology and microbiology at Baylor College of …
June 21, 2022
Across the country, firearm-related injuries and deaths are on the rise — especially among youth …
